The interest of gait markers in the identification of subgroups among fibromyalgia patients

Bernard Auvinet, Denis Chaleil, Jean Cabane, Anne Dumolard, Pierre Hatron, Robert Juvin, Michel Lanteri-Minet, Yves Mainguy, Laurence Negre-Pages, Fabien Pillard, Daniel Riviere, Yves-Michel Maugars, Bernard Auvinet, Denis Chaleil, Jean Cabane, Anne Dumolard, Pierre Hatron, Robert Juvin, Michel Lanteri-Minet, Yves Mainguy, Laurence Negre-Pages, Fabien Pillard, Daniel Riviere, Yves-Michel Maugars

Abstract

Background: Fibromyalgia (FM) is a heterogeneous syndrome and its classification into subgroups calls for broad-based discussion. FM subgrouping, which aims to adapt treatment according to different subgroups, relies in part, on psychological and cognitive dysfunctions. Since motor control of gait is closely related to cognitive function, we hypothesized that gait markers could be of interest in the identification of FM patients' subgroups. This controlled study aimed at characterizing gait disorders in FM, and subgrouping FM patients according to gait markers such as stride frequency (SF), stride regularity (SR), and cranio-caudal power (CCP) which measures kinesia.

Methods: A multicentre, observational open trial enrolled patients with primary FM (44.1 ± 8.1 y), and matched controls (44.1 ± 7.3 y). Outcome measurements and gait analyses were available for 52 pairs. A 3-step statistical analysis was carried out. A preliminary single blind analysis using k-means cluster was performed as an initial validation of gait markers. Then in order to quantify FM patients according to psychometric and gait variables an open descriptive analysis comparing patients and controls were made, and correlations between gait variables and main outcomes were calculated. Finally using cluster analysis, we described subgroups for each gait variable and looked for significant differences in self-reported assessments.

Results: SF was the most discriminating gait variable (73% of patients and controls). SF, SR, and CCP were different between patients and controls. There was a non-significant association between SF, FIQ and physical components from Short-Form 36 (p = 0.06). SR was correlated to FIQ (p = 0.01) and catastrophizing (p = 0.05) while CCP was correlated to pain (p = 0.01). The SF cluster identified 3 subgroups with a particular one characterized by normal SF, low pain, high activity and hyperkinesia. The SR cluster identified 2 distinct subgroups: the one with a reduced SR was distinguished by high FIQ, poor coping and altered affective status.

Conclusion: Gait analysis may provide additional information in the identification of subgroups among fibromyalgia patients. Gait analysis provided relevant information about physical and cognitive status, and pain behavior. Further studies are needed to better understand gait analysis implications in FM.

References

    1. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P. et al.The American College of Rheumatology 1990 Criteria for the classification of fibromyalgia report of the multicenter criteria committee. Arthritis Rheum. 1990;33:160–72. doi: 10.1002/art.1780330203.
    1. Stratz T, Schochat T, Färber L, Schweiger C, Müller W. Are there subgroups in fibromyalgia. J Musculoskel Pain. 1995;3(Suppl 1):15.
    1. Turk DC, Okifuji A, Sinclair JD, Starz TW. Pain, disability, and physical functioning in subgroups of patients with fibromyalgia. J Rheumatol. 1996;23:1255–62.
    1. Giesecke T, Williams DA, Harris RE, Cupps TR, Tian X, Tian TX, Gracely RH, Clauw DJ. Subgrouping of Fibromyalgia Patients on the Basis of Pressure-Pain Thresholds and Psychological Factors. Arthritis Rheum. 2003;10:2916–22.
    1. Thieme K, Turk DC, Flor H. Comorbid depression and anxiety in fibromyalgia syndrome: relationship to somatic and psychosocial markers. Psychosom Med. 2001;66:837–44.
    1. Müller W, Schneider EM, Stratz T. The classification of fibromyalgia syndrome. Rheumatol Int. 2007;27:1005–10. doi: 10.1007/s00296-007-0403-9.
    1. De Souza JB, Goffaux P, Julien N, Potvin S, Charest J, Marchand S. Fibromyalgia subgroups: profiling distinct subgroups using the Fibromyalgia Impact Questionnaire. A preliminary study. Rheumatol Int. 2009;29:509–15. doi: 10.1007/s00296-008-0722-5.
    1. Oswald J, Salemi S, Michel BA, Sprott H. Use of the Short-Form-36 Health Survey to detect a subgroup of fibromyalgia patients with psychological dysfunction. Clin Rheumathol. 2008;27:919–21. doi: 10.1007/s10067-008-0874-4.
    1. Wilson HD, Robinson JP, Turk DC. Toward the identification of symptom patterns in people with fibromyalgia. Arthritis Rheum. 2009;61:527–34. doi: 10.1002/art.24163.
    1. Aparicio VA, Ortega FB, Heredia JM, Carbonell-Baeza A, Sjöström M, Delgado-Fernandez M. Handgrip Strength Test as a Complement Tool in the Assessment of Fibromyalgia Severity in Women. Arch Phys Med Rehabil. 2011;92:83–88. doi: 10.1016/j.apmr.2010.09.010.
    1. Verghese J, Wang C, Lipton RB, Holtzer R, Xue X. Quantitative gait dysfunction and risk of cognitive decline and dementia. J Neurol Neurosurg Psychiatry. 2007;78:929–35. doi: 10.1136/jnnp.2006.106914.
    1. Snijders AH, Van de Warrenburg BP, Giladi N, Bloem BR. Neurological gait disorders in elderly people: clinical approach and classification. Lancet neurol. 2007;6:63–74. doi: 10.1016/S1474-4422(06)70678-0.
    1. Lundin-Olsson L, Nyberg L, Gustafson Y. "Stops walking when talking" as a predictor of falls in elderly people. Lancet. 1997;349:617.
    1. Hausdorff JM, Yogev G, Springer S, Simon ES, Giladi N. Walking is more like catching than tapping: gait in the elderly as a complex cognitive task. Exp Brain Res. 2005;164:541–48. doi: 10.1007/s00221-005-2280-3.
    1. Yogev-Seligmann G, Hausdorff JM, Giladi N. The role of executive function and attention in gait. Mov Disord. 2008;23:329–42. doi: 10.1002/mds.21720.
    1. Glass JM. Fibromyalgia and cognition. J Clin Psychiatry. 2008;69:20–4. doi: 10.4088/JCP.0708e20.
    1. Hausdorff JM, Peng CK, Goldberger AL, Stoll AL. Gait unsteadiness and fall risk in two affective disorders: a preliminary study. BMC Psychiatry. 2004;4:39. doi: 10.1186/1471-244X-4-39.
    1. Auvinet B, Bileckot R, Alix AS, Chaleil D, Barrey E. Gait disorders in patients with fibromyalgia. Joint Bone Spine. 2006;73:543–6. doi: 10.1016/j.jbspin.2005.10.020.
    1. Heredia Jiménez JM, Aparicio Garcia-Molina VA, Porres Foulquie JM, Delgado Fernández M, Soto Hermono VM. Spatial-temporal parameters of gait in women with fibromyalgia. Clin Rheumatol. 2009;28:595–8. doi: 10.1007/s10067-009-1101-7.
    1. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC. The mini-international neuropsychiatric interview (MINI). The development and validation of a structured diagnostic psychiatric interview for DSMIV and ICD10. J Clin Psychiatry. 1998;59:22–3.
    1. Spielberger CD, Gorsuch RL, Lushene RE. Manual for the State-Trait Anxiety Inventory. Palo Alto CA: Consulting Psychologists Press; 1983.
    1. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen psychiatry. 1961;4:561–71. doi: 10.1001/archpsyc.1961.01710120031004.
    1. Wolfe F, Anderson J, Harkness D, Bennett RM, Caro XJ, Goldenberg DL, Russell IJ, Yunus MB. Health status and disease severity in fibromyalgia: results of a six-centre longitudinal study. Arthritis Rheum. 1997;40:1571–9. doi: 10.1002/art.1780400905.
    1. Rosenstiel AK, Keefe FJ. The use of coping strategies in chronic low back pain patients: relationship to patient characteristics and current adjustment. Pain. 1983;17:33–44. doi: 10.1016/0304-3959(83)90125-2.
    1. Chalder T, Berelowitz G, Pawlikowska T, Watts L, Wessely S, Wright D, Wallace EP. Development of a fatigue scale. J Psychosom Res. 1993;37:147–53. doi: 10.1016/0022-3999(93)90081-P.
    1. Buysse DJ, Reynolds CF, Monk SR, Kupfer DJ. The Pittsburg Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry Research. 1989;28:193–213. doi: 10.1016/0165-1781(89)90047-4.
    1. Ware J, Kosinski M, Dewey J. How to score version 2 of the SF-36 Health Survey (Standard and acute forms) 3. Lincoln, RI: Quality Metric; 2000.
    1. Burckhardt CS, Clark SR, Bennett RM. The fibromyalgia impact questionnaire: development and validation. J Rheumatol. 1991;18:728–33.
    1. Paquet JM, Auvinet B, Chaleil D, Barrey E. Analysis of gait disorders in Parkinson's disease assessed with an acceloremeter. Rev Neurol (Paris) 2003;159:766–9.
    1. Beck AT, Steer RA, Carbin MG. Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation. Clin Psychol Rev. 1988. pp. 77–100.
    1. Williams AC, Richardson PH. What does the BDI measure in chronic pain? Pain. 1993;55:259–66. doi: 10.1016/0304-3959(93)90155-I.
    1. Bennett R. The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses. Clin Exp Rheumatol. 2005;23:S154–62.
    1. Okifuji A, Donaldson GW, Barck L, Fine PG. Relationship Between Fibromyalgia and Obesity in Pain, Function, Mood, and Sleep. The Journal of Pain. 2010;11:1329–1337. doi: 10.1016/j.jpain.2010.03.006.
    1. Montero-Odasso M, Casas A, Hansen KT, Bilski P, Gutmanis I, Wells JL, Borrie MJ. Quantitative gait analysis under dual-task in older people with mild cognitive impairment: a reliability study. Journal of Neuro Engineering and Rehabilitation. 2009;6:35. doi: 10.1186/1743-0003-6-35.
    1. Tiidus PM, Pierrynowski MR, Dawson KA. Influence of moderate training on gait and work capacity of fibromyalgia patients: a preliminary field study. J Sports Sci Med. 2002;4:122–7.
    1. Auvinet B, Chaleil D, Barrey E. Accelerometric Gait Analysis for Use in Hospital Outpatients. Rev Rhum [Engl Ed] 1999;66:389–397.
    1. Auvinet B, Berrut G, Touzard C, Moutel L, Collet N, Chaleil D, Barrey E. Reference data for normal subjects obtained with an accelerometric device. Gait and Posture. 2002;16:124–34. doi: 10.1016/S0966-6362(01)00203-X.
    1. Dubost V, Annweiler C, Aminian K, Najafi B, Herrmann FR, Beauchet O. Stride-to-stride variability while enumerating animal names among healthy young adults: result of stride velocity or effect of attention-demanding task? Gait Posture. 2008;27:138–43. doi: 10.1016/j.gaitpost.2007.03.011.
    1. Hausdorff JM. Gait variability: methods, modeling and meaning. J Neuroeng Rehabil. 2005;2:19. doi: 10.1186/1743-0003-2-19.
    1. Morris ME, Iansek R, Matyas TA, Summers JJ. Ability to modulate walking cadence remains intact in Parkinson's disease. J Neurol Neurosurg Psychiatry. 1994;57:1532–4. doi: 10.1136/jnnp.57.12.1532.
    1. Martin MY, Bradley LA, Alexander RW, Alarcón GS, Triana-Alexander M, Aaron LA, Alberts KR. Coping strategies predict disability in patients with fibromyalgia. Pain. 1996;68:45–53. doi: 10.1016/S0304-3959(96)03179-X.
    1. Sheridan PL, Solomont J, Kowall N, Hausdorff JM. Influence of executive function on locomotor function: divided attention increases gait variability in Alzheimer's disease. J Am Geriatr Soc. 2003;51:1633–7. doi: 10.1046/j.1532-5415.2003.51516.x.
    1. Goubert L, Crombez G, Van Damme S, Vlaeyen JWS, Bijttebier P, Roelofs J. Confirmatory factor analysis of the Tampa Scale for Kinesiophobia: Invariant two-factor model across low back pain patients and fibromyalgia patients. Clin J pain. 2004;20:103–10. doi: 10.1097/00002508-200403000-00007.
    1. Keefe FJ, Hill RW. An objective approach to quantifying pain behavior and gait patterns in low back pain patients. Pain. 1985;21:153–61. doi: 10.1016/0304-3959(85)90285-4.
    1. van Koulil S, Effting M, Kraaimaat FW, van Lankveld W, van Helmond T, Cats H, van Riel PLCM, de Jong AJL, Haverman JF , Evers AWM. Cognitive-behavioural therapies and exercise programmes for patients with fibromyalgia: state of the art and future directions. Ann Rheum Dis. 2007;66:571–81. doi: 10.1136/ard.2006.054692.
    1. Vaillant J, Guinot M, Auvinet B, Chaleil D, Dumolard A, Favre-Juvin A, Wuyam B, Juvin R. Effects of rehabilitation exercise training on functional balance tests and gait markers in patients with fibromyalgia. Physiotherapie. 2011;97(Supplement S1)
    1. Paleacu D, Shutzman A, Giladi N, Herman T, Simon ES, Hausdorff JM. Effects of pharmacological therapy on gait and cognitive function in depressed patients. Clin neuropharmacol. 2007;30:63–71. doi: 10.1097/01.wnf.0000240949.41691.95.
    1. Mork PJ, Vasseljen O, and Nilsen TIL. Association between physical exercise, body mass index, and risk of fibromyalgia: longitudinal data from the Norvegian Nord-Trondelag health study. Arthritis Care & Research. 2010;62:611–7. doi: 10.1002/acr.20118.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir